Opportunity
SAM #75F40126Q133903
FDA Solicitation for BioFlux 200+ or Equivalent Shear Flow System for Microscopy
Buyer
FDA Office of the Associate General Counsel for Administrative Law
Posted
June 09, 2026
Respond By
June 16, 2026
Identifier
75F40126Q133903
NAICS
334516
The U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), Laboratory of Cellular Hematology (LCH), is seeking a flexible shear flow system for microscopy. - Government Buyer: - U.S. Food and Drug Administration (FDA) - Center for Biologics Evaluation and Research (CBER) - Laboratory of Cellular Hematology (LCH) - Product/Service Requested: - One (1) BioFlux 200+ or equivalent flexible shear flow system for microscopy - Must be compatible with Nikon Eclipse Model TE200-U inverted microscope - Capable of programmable shear flow rates (0-200 dynes/cm2) - Supports pulsatile flow up to 120 bpm - Environmental control with dual gas input - Throughput up to 24 experiments per plate - Supports 24/48/96-well plate configurations - Includes computer workstation - Minimum one-year full manufacturer's warranty required - OEMs and Vendors: - BioFlux (by Fluxion Biosciences) is the referenced OEM; equivalent systems from other manufacturers are acceptable - Unique/Notable Requirements: - System must be compatible with existing Nikon Eclipse TE200-U microscope - Delivery is FOB destination to FDA CBER in Silver Spring, MD - Acquisition is set aside for small businesses under NAICS 334516 - Firm fixed-price contract with warranty included
Description
This FDA requirement is for a shear flow instrument system designed to mimic in vivo conditions to evaluate human platelets and red blood cells in their physiological environment. Please see the attached PDF file titled: FDA 75F40126Q133903.